Venture capitalists say investing in a medical device start-up has gotten riskier (StarTribune)
Investing in a medical device company these days does not come cheap. Venture capitalists said at a panel during Thursday’s MedTech Investing Conference in Minneapolis that the cost and risk of bringing medical device start-ups to market has gotten so expensive, it has caused at least one of them to change their business model.
Jan Garfinkle, managing director of Ann Arbor-based Arboretum Ventures, said her venture capital firm used to be 75 percent focused on medical devices and diagnostics. She es...
